Results 291 to 300 of about 20,538 (302)

A review of the assessment of dyskinesias

Movement Disorders, 1999
Bob J Van Hilten, R A C Roos
exaly  

Poor self-awareness of levodopa-induced dyskinesias in Parkinson's disease: Clinical features and mechanisms

Parkinsonism and Related Disorders, 2013
Alfonso Fasano, Giovanni Fabbrini, Marianna Sarchioto   +2 more
exaly  

Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study

Brain, 2015
Per Svenningsson, Klas Wictorin, Anders Björklund   +2 more
exaly  

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

Brain, 2004
R de la Fuente-Fernández, Vesna Sossi, Jian-Qiang Lu   +2 more
exaly  

Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature

Movement Disorders, 2001
J Eric Ahlskog, Manfred D Muenter
exaly  

Patient and caregiver perceptions of the social impact of advanced Parkinson’s disease and dyskinesias

Journal of Neural Transmission, 2012
Alexander Khlebtovsky, Eldad Melamed, Ilan Ziv   +2 more
exaly  

Therapeutic strategies to prevent and manage dyskinesias in Parkinson’s disease

Expert Opinion on Drug Safety, 2015
Manuela Pilleri, Angelo Antonini
exaly  

Psychogenic dyskinesias in patients with organic movement disorders

Movement Disorders, 1990
Anthony E Lang
exaly  

Dyskinesia with thiothixene

American Journal of Psychiatry, 1977
J, Ananth, A, Costin
openaire   +2 more sources

Riluzole for le vodopa-induced dyskinesias in advanced P arkinson's disease

Lancet, The, 1999
Doron Merims, Ilan Ziv, Ruth Djaldetti   +2 more
exaly